| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9960181 | Journal of the American College of Cardiology | 2005 | 8 Pages |
Abstract
Therapy with either a natriuretic peptide or vasodilator was associated with significantly lower in-hospital mortality than positive inotropic therapy in patients hospitalized with ADHF. The risk of in-hospital mortality was similar for nesiritide and nitroglycerin.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
William T. (FACC), Kirkwood F. (FACC), Gregg C. (FACC), Maria Rosa (FACC), Robert L. (FACC), Thierry H. MD, Mei L. PhD, Janet MS, ADHERE Scientific Advisory Committee and Investigators ADHERE Scientific Advisory Committee and Investigators,